UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction | (Commission | (I.R.S. Employer |
of incorporation or organization) | File Number) | Identification No.) |
|
|
|
|
| |
|
| |
| (Address of principal executive offices) |
|
|
| |
|
| |
| (Registrant’s telephone number, include |
|
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading |
| Name of each exchange on which |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On March 23, 2022, Alexander Schmitz, a member of the Board of Directors (the “Board”) of Rapid Micro Biosystems, Inc. (the “Company”) informed the Company that he does not intend to stand for reelection at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”). Mr. Schmitz is an independent Class I director and a member of the Audit Committee and Compensation Committee of the Board. He plans to serve out his current term as a member of the Board, Audit Committee and Compensation Committee until the Annual Meeting. Mr. Schmitz’s decision not to stand for reelection was not the result of any disagreement with the Company, including with respect to any matter relating to the Company’s operations, policies or practices. The Company would like to thank Mr. Schmitz for his dedication to the Company and his invaluable contributions over the past two years.
Document and Entity Information |
Mar. 23, 2022 |
|---|---|
| Document and Entity Information [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Mar. 23, 2022 |
| Entity File Number | 001-40592 |
| Entity Registrant Name | RAPID MICRO BIOSYSTEMS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 20-8121647 |
| Entity Address State Or Province | MA |
| Entity Address, Address Line One | 1001 Pawtucket Boulevard West, |
| Entity Address, Adress Line Two | Suite 280 |
| Entity Address, City or Town | Lowell |
| Entity Address, Postal Zip Code | 01854 |
| City Area Code | 978 |
| Local Phone Number | 349-3200 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Class A Common Stock, $0.01 par value per share |
| Trading Symbol | RPID |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Central Index Key | 0001380106 |
| Amendment Flag | false |